NCT06671600

Brief Summary

Parkinsonism, mainly caused by Parkinsons disease (PD), includes symptoms like tremors, stiffness, slow movements, and balance problems. These symptoms can make it hard for people to sleep well, which leads to a lower quality of life and can increase the risk of other health issues and cognitive decline. Osteopathic manipulative treatment (OMT) is a hands-on approach that may help improve sleep without the side effects of traditional treatments. While OMT has shown promise in enhancing sleep, no studies have specifically looked at its effects on sleep in Parkinson's disease patients. This study aims to see if OMT can help improve sleep quality, cognitive function, and daily activities for people with PD. The investigators will focus on treating specific areas of the body, using techniques that have helped improve sleep in the past. Participants will be divided into two groups: one will receive OMT, while the other will get a light touch treatment as a control. Sleep surveys and data from Fitbit devices will be used to compare the effects of the two treatments. Additionally, cognitive function will be assessed using a specific task called the Stroop task. This research could show that OMT can be a valuable addition to treatments for improving sleep quality in people with Parkinsons disease.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
20mo left

Started Apr 2025

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress40%
Apr 2025Dec 2027

First Submitted

Initial submission to the registry

November 1, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 4, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

April 8, 2025

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

March 18, 2025

Status Verified

March 1, 2025

Enrollment Period

1.7 years

First QC Date

November 1, 2024

Last Update Submit

March 13, 2025

Conditions

Keywords

OMMSleepParkinsons DiseaseOsteopathy

Outcome Measures

Primary Outcomes (5)

  • Heart Rate Variability

    Heart rate will be measured with a Fitbit watch

    5 weeks

  • Sleep quality

    sleep quality will be measured using a Fitbit device

    5 weeks

  • Sleep duration

    Sleep duration will be measured using a Fitbit device

    5 weeks

  • Oxygen saturation

    Oxygen saturation will be measured using a Fitbit device

    5 weeks

  • Sleep stage

    Time in each sleep stage will be recorded using FitBit

    5 weeks

Study Arms (2)

Treatment Group (OMT)

EXPERIMENTAL

For the Osteopathic Manipulative Medicine(OMM) treatment group, an osteopathic manipulative treatment protocol will be applied to the cranial, cervical, thoracic, and ribcage regions. OMM procedures performed on the treatment group will consist of 1. suboccipital decompression/release 2. base spread 3. occipitoatlantal (OA) decompression 4. venous sinus drainage 5. compression of the fourth ventricle 6. cervical myofascial (unilateralperpendicular stretch) 7. thoracic inlet release (direct or indirect) 8. Bilateral rib raising 9. thoracoabdominal diaphragm doming (direct technique) 10. pedal pump (Dalrymple lymphatic pump). All aforementioned techniques are based on the protocol from Foundations of Osteopathic Medicine.

Procedure: Osteopathic Manipulative Treatment

Sham- light touch

SHAM COMPARATOR

The sham group will serve as the control group and will receive a light touch-control procedure based on prior study utilizing light touch

Procedure: Sham (No Treatment)

Interventions

Osteopathic manipulative treatment(OMT) protocol will be applied to the cranial, cervical, thoracic, and ribcage regions. OMT procedures performed on the treatment group will consist of 1. suboccipital decompression/release 2. base spread 3. occipitoatlantal (OA) decompression 4. venous sinus drainage 5. compression of the fourth ventricle 6. cervical myofascial (unilateral perpendicular stretch) 7. thoracic inlet release (direct or indirect) 8. Bilateral rib raising 9. thoracoabdominal diaphragm doming (direct technique) 10. pedal pump (Dalrymple lymphatic pump)

Treatment Group (OMT)

The sham group will serve as the control group and will receive a light touch-control procedure based on prior study utilizing light touch.

Sham- light touch

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Must have a diagnosis of Parkinson's disease as per a neurologist
  • Severity of 0-3 on the Hoehn and Yahr (H-Y) Scale
  • Able to receive OMM
  • Able to be in a supine and prone position.
  • Able to wear a Fitbit watch and an oxygen saturation ring for the duration of the study (including when sleeping).
  • Have sleep disturbance complaints.

You may not qualify if:

  • Patients on medications that affect sleep
  • Have a pre-existing sleep disorder diagnosis
  • Those who have a concurrent neurological diagnosis that would confound sleep patterns (ie. narcolepsy)
  • Contraindications to the OMM techniques used in this protocol
  • Severity of 4 and 5 on the Hoehn and Yahr Scale

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Hablitz LM, Nedergaard M. The Glymphatic System: A Novel Component of Fundamental Neurobiology. J Neurosci. 2021 Sep 15;41(37):7698-7711. doi: 10.1523/JNEUROSCI.0619-21.2021.

    PMID: 34526407BACKGROUND

MeSH Terms

Conditions

Parkinson Disease

Interventions

Manipulation, Osteopathicsalicylhydroxamic acid

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

Musculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Central Study Contacts

Sheldon Yao, Doctor of Osteopathic Medicine

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly divided into either the treatment group who will receive OMT and the sham group who will receive light touch.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 1, 2024

First Posted

November 4, 2024

Study Start

April 8, 2025

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2027

Last Updated

March 18, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share